Dr Olzscha investigates how small protein tags, known as post-translational modifications, change the structure and interaction of proteins. This has implications for drug development in cancer, but also neurodegenerative diseases including Alzheimer’s, Parkinson’s and Huntington’s disease.
- Epigenetics of cancer
- Neurodegenerative diseases
- Drug development
- Personalised medicine
Dr Olzscha has experience of print media and has presented her research in video interviews.